Zehui Wang is a New York, New York based neurologist who is specialized in Neurology. Active license number of Zehui Wang is MD476468 for Neurology in Pennsylvania. Her current practice location is 550 1st Ave, New York. Patients can reach her at 215-662-3898. Zehui Wang is M.D. in Neurology and her NPI number (Unique professional ID assigned by NPPES) is 1942706486. Zehui Wang specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Zehui Wang speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Zehui Wang
Specialization:
Neurology
Gender:
Female
Credentials:
M.D.
Practice Address:
550 1st Ave, New York, New York, 10016-6402
Phone:
215-662-3898
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1942706486
NPI Enumeration Date:
03 Apr, 2018
NPI Last Update On:
01 Jul, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Zehui Wang are as mentioned below.
License Number
Specialization
State
Status
MD476468
Neurology
Pennsylvania
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Zehui Wang 550 1st Ave, New York, New York
Zip:
10016-6402
Patients can reach Zehui Wang at 550 1st Ave, New York, New York or can call to book an appointment on 215-662-3898.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.